Savara inc. (SVRA)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Net sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Licensing revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Grant and award revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

0

0

0

Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gross margin

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Operating expenses:
Research and development

41,962

38,781

39,915

39,849

38,653

37,173

33,750

29,207

24,103

18,512

8,953

6,129

3,255

8,182

-5,478

-290

6,154

4,321

26,038

24,110

21,196

19,435

18,022

15,723

13,740

12,902

11,039

10,045

0

0

0

General and administrative

13,300

13,081

13,036

13,373

11,648

10,654

10,174

8,512

11,114

11,081

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of acquired IPR&D

-

-

-

-

-

21,692

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Impairment of goodwill

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Depreciation

-

-

-

-

-

-

-

-

-

363

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,220

-

10,845

10,840

10,800

9,488

9,237

8,941

8,671

8,518

8,187

7,899

0

0

0

Transaction-related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

271

315

313

331

79

0

0

0

-

-

Transaction-related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Depreciation and amortization

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

148

-

130

117

103

85

71

56

42

40

39

66

0

0

0

Equity in loss of investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Total operating expenses

82,345

79,025

60,763

61,105

50,858

70,045

66,094

59,853

57,289

29,956

16,053

12,740

5,380

11,348

-7,727

-1,129

7,069

5,977

37,013

35,069

32,090

29,279

27,647

25,033

22,785

21,539

19,035

17,986

0

0

0

Loss from operations

-82,345

-79,025

-60,763

-61,105

-50,858

-70,045

-66,094

-59,853

-57,289

-29,956

-15,653

-12,340

-4,980

-10,948

7,781

1,183

-7,015

-5,923

-37,013

-35,069

-32,090

-29,279

-27,647

-25,033

-22,785

-21,539

-19,035

-17,986

0

0

0

Other income, net:
Interest expense, net

-210

-70

133

239

95

11

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reduction of fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Reduction of fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

139

-

113

99

84

69

67

66

60

60

60

62

0

0

0

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

687

178

452

3,199

3,110

3,104

2,585

0

0

0

-

-

-

-

-

-

-

0

0

0

Foreign currency exchange gain (loss)

137

-78

151

28

73

71

94

30

-247

-218

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax credit income

1,070

1,213

1,276

1,332

1,494

1,454

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-134

-213

-266

-120

-85

-64

48

-5

-176

-280

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

863

852

1,294

1,479

1,577

1,472

1,224

609

-2,335

-3,475

-3,741

-3,347

-784

-332

-3,114

-3,132

-3,065

-3,076

10

25

59

508

486

486

454

-1

-0

-8

0

0

0

Loss before income taxes

-81,482

-78,173

-59,469

-59,626

-49,281

-68,573

-64,870

-59,244

-59,624

-33,431

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-

-

-

-

-

-7,057

-7,365

-7,482

-7,952

-3,634

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before cumulative effect of change in accounting principle

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Cumulative effect of change in accounting principle

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net loss

-81,482

-78,173

-56,967

-57,124

-46,779

-61,516

-57,505

-51,762

-51,672

-29,797

-17,733

-14,143

-4,690

-10,923

4,195

-2,490

-10,590

-8,999

-36,992

-34,946

-31,947

-28,702

-27,093

-24,480

-22,270

-21,480

-18,974

-17,932

0

0

0

Accretion of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

578

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend on beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Deemed dividends on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-30,779

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net loss per share:
Basic and diluted

-0.27

-0.74

-0.30

-0.57

-0.34

-0.26

-0.36

-0.37

-0.86

1.07

-0.28

-0.90

-1.65

1.96

-1.21

-1.97

-4.40

-9.30

-0.06

-0.06

-0.06

-0.05

-0.06

-0.06

-0.06

-0.02

-0.05

-0.09

-0.12

-0.07

-0.09

Weighted average common shares outstanding:
Basic and diluted

57,364

43,926

41,727

38,440

36,016

35,967

34,483

31,433

31,318

29,037

24,209

13,807

3,029

1,546

2,707

1,043

2,544

-481,325

163,614

162,128

159,458

145,708

123,287

115,587

105,053

103,617

102,710

53,749

46,265

47,715

47,715

Other comprehensive loss:
Loss on foreign currency translation

-199

-296

-723

-392

-1,339

-773

-367

86

1,793

1,595

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-81,482

-78,173

-56,967

-57,124

-46,779

-61,516

-57,505

-51,762

-51,672

-29,797

-17,733

-14,143

-4,690

-10,923

4,195

-2,490

-10,590

-8,999

-36,992

-34,946

-31,947

-28,702

-27,093

-24,480

-22,270

-21,480

-18,974

-17,932

0

0

0

Other comprehensive (loss)/income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-

34

28

24

-4

3

-9

-15

-19

0

0

0

0

0

Unrealized gain on short-term investments

70

79

123

148

65

15

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stock

-

-

-

-

-

-

-

-

-

-30,779

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total comprehensive loss

-81,611

-78,390

-57,567

-57,368

-48,053

-62,274

-57,887

-51,709

-49,949

-28,248

-17,048

-13,762

-5,160

-11,514

4,222

-2,503

-10,591

-8,999

-36,958

-34,918

-31,923

-28,706

-27,089

-24,490

-22,285

-21,499

-19,001

-17,938

0

0

0